Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Thrombosis and Haemostasis

• Publication date

  2015-10-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1160/th15-04-0300PMID 26510894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinases and peripheral arterial disease.

  2015cited by this paper
• Visualization of nitric oxide production by individual platelets during adhesion in flowing blood.

  2015cited by this paper
• Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation

  2014cited by this paper
• Phosphoinositide 3-Kinases p110&agr; and p110&bgr; Have Differential Roles in Insulin-Like Growth Factor-1–Mediated Akt Phosphorylation and Platelet Priming

  2014cited by this paper
• Plasmin Cleavage of von Willebrand Factor as an Emergency Bypass for ADAMTS13 Deficiency in Thrombotic Microangiopathy

  2014cited by this paper
• Platelets and matrix metalloproteinases

  2013cited by this paper
• Intracellular matrix metalloproteinase-2 (MMP-2) regulates human platelet activation via hydrolysis of talin

  2013cited by this paper
• High shear flow induces migration of adherent human platelets

  2011cited by this paper
• Regulating thrombus growth and stability to achieve an optimal response to injury

  2011cited by this paper
• Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke

  2011cited by this paper
• Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood

  2011cited by this paper
• Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events.

  2011cited by this paper
• Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation.

  2011influential reference
• Matrix metalloproteinases and peripheral arterial disease

  2010cited by this paper
• Hyperglycemia-Induced Platelet Activation in Type 2 Diabetes Is Resistant to Aspirin but Not to a Nitric Oxide–Donating Agent

  2010cited by this paper
• Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site.

  2009cited by this paper
• Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo

  2009influential reference
• Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins.

  2009cited by this paper
• Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation

  2009cited by this paper
• Cell Adhesion Mechanisms in Platelets

  2008cited by this paper
• MMP‐2 regulates human platelet activation by interacting with integrin αIIbβ3

  2008cited by this paper
• Potentiation and priming of platelet activation: a potential target for antiplatelet therapy.

  2008cited by this paper
• Novel Therapeutic Targets at the Platelet Vascular Interface

  2008cited by this paper
• MMP-2 regulates human platelet activation by interacting with integrin alphaIIbbeta3.

  2008cited by this paper
• Matrix metalloproteinases in platelet function: coming of age

  2008cited by this paper
• Platelets release active matrix metalloproteinase‐2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin

  2007influential reference
• NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.

  2007cited by this paper
• Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation.

  2006influential reference
• A novel nitric oxide‐releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression 1

  2005cited by this paper
• Rossiello MR, Momi S, Caracchini R, et al. A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression

  2005cited by this paper
• Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase‐2 on platelet aggregation

  2005influential reference
• Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions.

  2004cited by this paper
• Thrombopoietin increases platelet adhesion under flow and decreases rolling

  2003cited by this paper
• Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus.

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Imbalance Between Tissue Inhibitor of Metalloproteinase-4 and Matrix Metalloproteinases During Acute Myoctardial Ischemia-Reperfusion Injury

  2003cited by this paper
• Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function.

  2001cited by this paper
• Human endothelial gelatinases and angiogenesis.

  2001cited by this paper
• Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.

  2001cited by this paper
• A revised model of platelet aggregation.

  2000cited by this paper
• Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation.

  2000cited by this paper
• Effect of strenuous, acute exercise on alpha2-adrenergic agonist-potentiated platelet activation.

  1999cited by this paper
• Effect of adenosine derivatives on in vitro thrombus formation induced by shear stress.

  1999cited by this paper
• Effect of Strenuous, Acute Exercise on α2-Adrenergic Agonist–Potentiated Platelet Activation

  1999cited by this paper
• A new perfusion chamber to detect platelet adhesion using a small volume of blood.

  1998cited by this paper
• Release of gelatinase A during platelet activation mediates aggregation

  1997cited by this paper
• Platelets and shear stress.

  1996cited by this paper
• Decreased platelet function in aortic valve stenosis: high shear platelet activation then inactivation.

  1995cited by this paper
• Aggregate formation is more strongly inhibited at high shear rates by dRGDW, a synthetic RGD-containing peptide.

  1993cited by this paper
• Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C.

  1993cited by this paper
• Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation.

  1992cited by this paper
• Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.

  1988cited by this paper
• Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's disease.

  1987cited by this paper
• Changes in surface-bound and exchangeable calcium during platelet activation.

  1982cited by this paper

• Effects of 3,5,4′-tri-[4-(nitrooxy)butanoyl]oxy resveratrol, a new nitric oxide-releasing derivative of resveratrol, on platelet activation

  2025cites this paper
• Diabetes mellitus exacerbates inflammation in a murine model of ligature-induced peri-implantitis: A histological and microtomographic study.

  2024cites this paper
• Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity.

  2024cites this paper
• Development of Personalized Thrombogenesis and Thrombin Generation Assays to Assess Endothelial Dysfunction in Cardiovascular Diseases

  2023cites this paper
• Release of MMP-2 in the circulation of patients with acute coronary syndromes undergoing percutaneous coronary intervention: Role of platelets.

  2022cites this paper
• Platelets and Matrix Metalloproteinases: A Bidirectional Interaction with Multiple Pathophysiologic Implications

  2021cites this paper
• Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway

  2021cites this paper
• A p.Arg127Gln variant in GPIbα LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD

  2021cites this paper
• Development of anti-matrix metalloproteinase-2 (MMP-2) nanobodies as potential therapeutic and diagnostic tools.

  2020cites this paper
• Advances on fluid shear stress regulating blood-brain barrier.

  2020cites this paper
• Sub-Cellular Localization of Metalloproteinases in Megakaryocytes

  2018cites this paper
• A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling.

  2017cites this paper
• Platelet Activation Under Conditions of Flow

  2017cites this paper
• Matrix metalloproteinase12 facilitated platelet activation by shedding carcinoembryonic antigen related cell adhesion molecule1.

  2017cites this paper
• Matrix Metalloproteinases and Platelet Function.

  2017cites this paper